Clinical Trial Update: Evaluation of IR3535 as a Spatial Repellent for Malaria Control. [NA]

View source ↗

Summary

This clinical trial update concerns evaluating IR3535 as a spatial repellent for malaria control. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• IR3535 (ethyl butylacetylaminopropionate)

Snippet

Sponsor: Universidade Nova de Lisboa | Conditions: Malaria | NA | Status: ACTIVE_NOT_RECRUITING